TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04715607

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Sequence of testing.
Description: The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Sequence of testing.
Description: The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.
Study: NCT06448754

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Participants will receive carboplatin via IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Participants will receive carboplatin via IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Participants will receive pemetrexed via IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Participants will receive pemetrexed via IV infusion.
Study: NCT06017219

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: spermidine
Description: spermidine

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: spermidine
Description: spermidine
Study: NCT06297486

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SPK-8011
Description: Participants will receive a single dose of SPK-8011, administered by intravenous (IV) infusion, on Day 1.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SPK-8011
Description: Participants will receive a single dose of SPK-8011, administered by intravenous (IV) infusion, on Day 1.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: SPK-8011
Description: Participants will receive a single dose of SPK-8011, administered by intravenous (IV) infusion, on Day 1.
Study: NCT04752423

Intervention type: OTHER
Intervention: Pre operative assessment
Description: Anxiety assessment : Numeric rating scale (patient and caregiver), APAIS scale (patient), Covi Scale (Caregiver)~Verbalization : anesthesia-related concerns (expressed by patient and considered by caregiver)

Intervention type: OTHER
Intervention: Pre operative assessment
Description: Anxiety assessment : Numeric rating scale (patient and caregiver), APAIS scale (patient), Covi Scale (Caregiver)~Verbalization : anesthesia-related concerns (expressed by patient and considered by caregiver)
Study: NCT06177665

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: Ultrasound(US)-guided erector spinae plan block(ESP) with 20 ml 0,25% bupivacaine at T4 vertebra level will performe preoperatively to all patients in the ESP group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhomboid Intercostal Block
Description: Ultrasound(US)-guided rhomboid intercostal block(RIB) with 20 ml 0,25% bupivacaine at T5-T6 vertebra level will performe preoperatively to all patients in the RIB group.
Study: NCT06211569

Intervention type: OTHER
Intervention: Usual follow-up
Description: Usual follow-up
Study: NCT04715607

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Sequence of testing.
Description: The participants will be tested in the following sequences of sampling technique: (1) nasopharyngeal swab, oropharyngeal swab, and salvia collection OR (2) oropharyngeal swab, salvia collection, and nasopharyngeal swab OR (3) salvia collection, nasopharyngeal swab, and oropharyngeal swab. Only the sequence is different in the different arm, while the sampling technique for each method is the same in all arms.
Study: NCT04853810

Intervention type: OTHER
Intervention: CUTADIAB questionnaire
Description: During a regular diabetes follow-up consultation, the patient is asked to complete the CUTADIAB questionnaire on a tablet, entirely dedicated to the study
Study: NCT06173245

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravitreal injection of ranibizumab
Description: These patients were received three intravitreal injection of ranibizumab with one month interval. 3D-OCT by enhanced depth spectral-domain imaging (EDI-OCT) was done preoperative and a month after every injection.~All patients recieved topical anesthesia as 0.5 mg/0.05 ml , ranibizumab is injected 4 mm (3.5 mm in Pseudophakia) from the limbus intravitreally (in the lower temporal quadrant) by a needle (27gauge).
Study: NCT05181982

Intervention type: OTHER
Intervention: FIT contract with global treatment budget
Description: Several SHI funds have established a contract (duration = at least eight year) with the model hospital for an alternative remuneration / financing of patients treated in the model hospital (FIT hospital, Pfalzklinikum). This contract encourages the model hospital an alternative treatment of their patients (insured with the involved SHI funds), for example fewer inpatient and more outpatient treatment. The contract is based on a global treatment budget (pre-defined fix budget for a specified number of patients independent from the setting of treatment in the hospital).
Study: NCT05778370

Intervention type: DEVICE
Intervention: Swept Source Optical Coherence Tomography(Topcon DRI Triton)
Description: Topcon DRI Triton

Intervention type: DEVICE
Intervention: Swept Source Optical Coherence Tomography(Topcon DRI Triton)
Description: Topcon DRI Triton

Intervention type: DEVICE
Intervention: Swept Source Optical Coherence Tomography(Topcon DRI Triton)
Description: Topcon DRI Triton
Study: NCT06078462

Intervention type: OTHER
Intervention: job related activities
Description: Different types of effort offered by female physiotherapist and female dentist during clinical practicing with patients in internship year

Intervention type: OTHER
Intervention: job related activities
Description: Different types of effort offered by female physiotherapist and female dentist during clinical practicing with patients in internship year
Study: NCT05918068

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day
Description: Metformin 500 mg/day in addition to non-pharmacological therapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin 500 mg/day
Description: Metformin 500 mg/day in addition to non-pharmacological therapy
Study: NCT05630261

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-help CBT-I
Description: The intervention will cover the following topics: (a) physiological linkage between the brain and stress, (b) sleep hygiene, (c) stimulus control, (d) sleep restriction, (e) cognitive restructuring, and (f) positive psychology. Each weekly session will be divided into 6-8 chapters. Chapters are supported by short videos and interactive games. Homework activities will be assigned after each session.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-help CBT-D
Description: The intervention will cover the following topics: (a) physiological linkage between the brain and stress, (b) emotion management, (c) cognitive restructuring, (d) behavioral activation, and (e) positive psychology. Each weekly session will be divided into 6-8 chapters. Some chapters are supported by short videos and e-worksheets. Homework activities will be assigned after each session, which include weekly record of emotions or between-session practice.
Study: NCT05918068

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Metformin 500 mg/day plus vitamin B6 300 mg/day
Description: Metformin 500 mg/day plus vitamin B6 300 mg/day in addition to non-pharmacological therapy

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)

Intervention type: OTHER
Group type: OTHER
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: non-pharmacological therapy
Description: non-pharmacological therapy (healthy lifestyle modifications)
Study: NCT05591339

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG vaccine (two doses, 4 weeks apart)
Description: BCG vaccine provided intradermally at the upper arm.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo (Two doses, 4 weeks apart)
Description: Participants randomized to the control group (placebo) will receive one 0.1 ml dose sterile 0.9 % NaCl by intradermal injection in the left deltoid region.
Study: NCT05980117

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Description: Remimazolam (1.0mg IV) titrated to modified observer's assessment of sedation score of 3 -4 during cataract surgery.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Description: Midazolam (0.5-2mg IV) titrated to modified observer's assessment of sedation score of 3 - 4 during cataract surgery.
Study: NCT06480773

Intervention type: DRUG
Intervention: standard of care chemotherapy
Description: intravenous Paclitaxel or the combination of Bleomycin and Vincristine.
Study: NCT04216316

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Berzosertib
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Correlative studies

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine Hydrochloride
Description: Given IV
Study: NCT06576700

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Grape Seed Extracts
Description: 2 capsules/day for 8 weeks
Study: NCT06339944

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sensory motor training
Description: in this group 17 participants will receive conventional therapy and then followed by kinesthetic exercises. 3 sessions per week includes 10 repetitions with 3sets.
Study: NCT04216316

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Given IV
Study: NCT06432517

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Power Bike（Ergoselect 100P）
Description: Changes in the participants' energy balance will be measured through moderate to high intensity exercise. Observation of food intake, body composition, metabolic rate, food assimilation rate.
Study: NCT06339944

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesthetic exercises
Description: in this group 17 participants will receive conventional therapy and then followed by kinesthetic exercises. 3 sessions per week includes 10 repetitions with 3sets.
Study: NCT05271149

Intervention type: OTHER
Group type: OTHER
Intervention: Routine Physical Therapy
Description: Routine physical therapy and orthosis

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine Physical Therapy
Description: Routine physical therapy and orthosis
Study: NCT05393869

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: OTHER
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health communications
Description: Participants are assigned to view health communications with risk and efficacy statements.
Study: NCT06252558

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Symbiotic
Description: One-a-day administration of a capsule supplement containing:15 billion CFU probiotic blend (Lactobacillus acidophilus La-14, Bifidobacterium longum BB536, Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus GG, Lactobacillus gasseri Lg-36) and 250mg of chicory root inulin.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily fiber capsule containing microcrystalline cellulose
Study: NCT05938660

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: acupressure at Sanyinjiao point
Description: When pressing Sanyinjiao point, the subject should be in a comfortable sitting position. Press the acupoints with the thumb until the subject feels soreness, then press and knead in a circle according to the strength acceptable to the subject. Press and knead once a second, and rest for 1 second every 5 seconds are one cycle, the speed is 10 cycles/minute, and it lasts for five minutes.
Study: NCT06318637

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baby Wash/Shampoo
Description: Marketed baby wash/shampoo to be used as needed.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Daily Activities
Description: Participants to follow their typical daily activities with their baby.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Body Lotion
Description: Marketed body lotion to be used as needed.
Study: NCT05698381

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liquid vinegar
Description: 2 tablespoons consumed twice daily with meals

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vinegar pill
Description: 2 pills consumed upon waking
Study: NCT04562649

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Wise App with medication adherence reminders
Description: The Intervention group will receive the Wise App that delivers medication adherence reminders.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHW Sessions
Description: The Intervention group will complete sessions with a community health worker (CHW).
Study: NCT06014450

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Prophylactic Cranial Irradiation for experiment arm
Description: Prophylactic Cranial Irradiation DT30Gy/10f

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: Prophylactic Cranial Irradiation for experiment arm
Description: Prophylactic Cranial Irradiation DT30Gy/10f
Study: NCT06262698

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiment group
Description: The experimental group will receive six weeks of HBM-based training.

Intervention type: OTHER
Group type: OTHER
Intervention: Pre-post test
Description: The TCM Attitude Scale (CACMAS), Medication Health Belief Scale

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-post test
Description: The TCM Attitude Scale (CACMAS), Medication Health Belief Scale
Study: NCT05432271

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to calorie information
Description: Calories for all beverages and foods

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to healthy labels only
Description: Green labels only for beverages and foods scored as healthy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to healthiness information
Description: All beverages and foods labeled as either healthy (green), moderately healthy (yellow), or less healthy (red)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to physical activity equivalents
Description: All beverages and foods labeled with physical activity required to burn their calories

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to high in nutrient warning labels
Description: Warning labels only for beverages and foods that exceed the thresholds for sugar, sodium, saturated fat, or calorie content
Study: NCT05621083

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega- 3
Description: In the fish oil supplement period, the participants will receive concentrated fish oil which is equal to in total 2.3 g EPA+DHA per day during 6 weeks.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: HOSO
Description: In the HOSO period, the participants will receive similar amount of HOSO per day during 6 weeks.
Study: NCT05464290

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NANOfat grafting
Description: The nanofat in a 10 cc syringe connected with a 23 gauge needle is then used to create a lot of tunnels in the plane of the sclerotic tissues and the nanofat is delivered into the tunnels. During injection the area is massaged to achieve complete releasing of fibrous tissue that was feel under the fingers.
Study: NCT04090996

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dual TAsk
Description: Motor assessment includes:~* posturographic examination in Single-task (ST) and Double-task (DT)~* an analysis of ST and DT walking;~* Timed Up and Go (TUG) performances in real (rTUG) and imagined (iTUG) versions;
Study: NCT06349720

Intervention type: BEHAVIORAL
Intervention: respiratory rehabilitation
Description: Emote respiratory rehabilitation:Patients wear monitoring devices and upload real-time monitoring data such as vital signs through the FREE rehabilitation app installed on their personal phones. Medical staff monitor changes in patients' vital signs in real time through the FREE rehabilitation app on the medical end, and adjust respiratory rehabilitation plans based on their phone or video guidance.~Outpatient respiratory rehabilitation:Traditional outpatient respiratory rehabilitation is based on a group approach, with individualized intensity determined based on baseline assessment results, and is conducted under supervision twice a week for a period of 12 weeks.
Study: NCT04787601

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Cognıtıve-based neuromuscular exercıses will be applied.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Classic Training
Description: Classic match preparation training

Intervention type: OTHER
Group type: OTHER
Intervention: Classic Training
Description: Classic match preparation training
Study: NCT05274074

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social LEAF
Description: Social LEAF is an adaptation of the Life Enhancing Activities for Family Caregivers program to focus on social relationships and loneliness. Social LEAF is a six-session group program provided by video-conference that teaches caregivers coping skills to improve social relationships and social connection. Social LEAF is delivered in groups of up to 10 caregivers via videoconference and will consist of six weekly hour-long discussion-based classes to teach positive coping skills around improving social relationships. Each week will focus on a skill from the original LEAF study adapted to the group and social context.
Study: NCT06533033

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rapid Release Capsules Melatoni
Description: Twenty-five will be given melatonin therapy in combination with the conventional treatment.~2 tablets,30 minutes before sleeping once daily for 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide ointment, Kenacort-A orabase
Description: Twenty-five will be given topical corticosteroid applied twice to three times daily.~Topical antifungal will be applied three to four times daily. This conventional treatment will be given to the patients for 8 weeks
Study: NCT05368220

Intervention type: OTHER
Intervention: Whole genome sequencing
Description: Each participant will have WGS performed in order to report on clinically actionable genetic variation in diabetes.

Intervention type: OTHER
Intervention: Whole genome sequencing
Description: Each participant will have WGS performed in order to report on clinically actionable genetic variation in diabetes.
Study: NCT06171542

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CTM Injection
Description: All glenohumeral joint injections will be performed by a physician under the guidance of either ultrasound or fluoroscopy to ensure and document intra-articular needle placement. 2cc of CTM Flow will be injected. The glenohumeral joint will be injected with the medication under the discretion of the treating surgeon.
Study: NCT05949723

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Golf simulator device
Description: The golf simulator can accurately predict the flight trajectory and landing point of the ball using high-speed moving object measurement technology, giving the user the impression that they are playing on a real golf course.